Oral semaglutide
Sold by beyondMD · Oral tablet · every oral semaglutide record
Price
No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.
We earn nothing from this link. It opens beyondMD's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | Not disclosed |
| Prescriber | Live visit |
| Cancellation | Clinical services are nonrefundable once started or completed. Medication cancellation generally ends once pharmacy processing, preparation, compounding or dispensing begins, and shipped prescriptions cannot be returned. Cancel future eligible renewals before the next scheduled charge; cancellation does not refund completed care or medication already processed. The process page separately says patients are charged only if approved; confirm the applicable clinical-service charge before paying. https://beyondmd.com/refund-cancellation-policy/ |
| Membership | None. “Free membership includes provider access, program support, and member benefits.” |
| Consult fee | Not disclosed |
Recorded from beyondmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. October 2026 — The catalog advertises oral semaglutide starting at $149, while the older product-page excerpt says $125. The product page could not be reread in this pass. These are unresolved offers, not a verified price change or a confirmed monthly bill.
- 2. October 2026 — The oral semaglutide heading advertises $149, while the body says pricing starts at $125 and the FAQ describes approximately $125 per month. These conflicting advertisements do not establish one payable invoice. Consultation is required and shipping costs extra. The page describes a daily swallowed tablet; it does not identify a named brand product. https://beyondmd.com/all-programs/oral-semaglutide/
- 3. October 2026 — The process page describes a scheduled private telehealth consultation and separately says a live or video visit may depend on the patient’s state. This supports a live consultation pathway without establishing an independent asynchronous prescribing option. Generic all-50-state footer language conflicts with the process page’s “most states” wording; program eligibility remains state- and prescription-dependent. No dispensing pharmacy is named in the program or process pages.
- 4. October 2026 — A provider consultation is required, but the source does not establish whether it carries a separate charge or is included in the program. Separately stated shipping fees do not establish a consultation fee. https://beyondmd.com/all-programs/oral-semaglutide/
12 further notes concern other beyondMD programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.